US20130218037A1

US20130218037A1 - Interbeat interval monitoring and ectopic beat removal

Info

Publication number: US20130218037A1
Application number: US13/839,341
Authority: US
Inventors: Ernst RAEDER
Original assignee: Research Foundation of State University of New York
Current assignee: Research Foundation of State University of New York
Priority date: 2007-08-02
Filing date: 2013-03-15
Publication date: 2013-08-22
Also published as: US20150223711A1; US20110166466A1; WO2009018570A3; WO2009018570A2; US8417326B2

Abstract

Disclosed is an apparatus and method for ambulatory, real-time detection of removal of ectopic beats by obtaining consecutive patient heartbeats, and recognizing an ectopic beat by detecting a signature short-long sequence in an interbeat interval of the obtained heartbeats, with the signature short-long sequence including an ectopic coupling interval followed by a compensatory pause between RR intervals.

Description

PRIORITY

This application is a continuation application of U.S. application Ser. No. 12/671,847 filed Feb. 2, 2010, and claims priority to PCT/US2008/072099 filed Aug. 4, 2008, to U.S. Provisional Application No. 60/953,508, filed Aug. 2, 2007, and to U.S. Provisional Application No. 61/084,389, filed Jul. 29, 2008, the contents of each of which is incorporated herein by reference.

BACKGROUND OF THE INVENTION

The present invention applies an algorithm for detection of Atrial Fibrillation (AF), which is one of the most common cardiac arrhythmias, afflicting approximately 2-3 million Americans. The incidence and prevalence of AF increase with age. With the graying of the baby boomers, it is estimated that 12-16 million individuals may be affected by 2050 and be at risk of significant mortality and morbidity from this arrhythmia.
AF has a prevalence of 17.8% and an incidence of 20.7/1,000 patient years in individuals older than 85. At age 55, the lifetime risk of developing AF is approximately 23%. AF is an independent risk factor for death (relative risk in men is 1.5 and in women 1.9). Furthermore, AF is a major cause of ischemic stroke, the impact of which increases with age and reaches 23.5% in patients older than 80. Accurate detection of AF is crucial since effective treatment modalities such as chronic anticoagulation and antiarrhythmic therapy, as well as radiofrequency ablation, are available but carry risks of serious complications. Despite the ubiquity of the arrhythmia, its diagnosis rests largely on the presence of symptoms and on serendipity. Unfortunately, since patients are often unaware of their irregular pulse, the diagnosis is often only established during a fortuitous doctor visit. If episodes of AF occur interspersed with normal sinus rhythm, the diagnosis presents an even greater challenge.
When AF is suspected, ambulatory monitoring can be performed in an attempt to document the arrhythmia. However, this approach is time consuming and not cost-effective for screening asymptomatic populations. Limitations of currently available technology include electrocardiography (for less than 10 seconds) and long-term monitoring. Ambulatory Holter monitoring is limited to no more than 48 hours and is cumbersome because it requires several leads connecting to a device worn on the patient's waist. After completion of the recording, the monitor is returned for data analysis by a cardiologist. Accordingly, real-time monitoring is not possible with conventional devices.
Conventional monitoring devices also include event monitors, which are small devices carried by a patient for up to 30 days. The patient will activate the event monitor upon when experiencing an irregular heart beat. A cardiologist will subsequently analyze recordings obtained by the event monitor.
For patients with very infrequent but potentially serious rhythm disturbances, an implantable loop recorder can be used. The implantable loop recorder continually records and overwrites the electrocardiogram for more than one year. When patients experience an event, they can freeze the recording and transmit the information to a cardiologist.
Several companies presently offer ambulatory heart monitors without AF detection capability. For example, CardioNet provides a 3-lead ECG monitor system which records and transmits data wirelessly to a hand held PDA for subsequent modem or Internet transmission. See, Rothman, et al., Diagnosis of Cardiac Arrhythmias Journal of Cardiovascular Electrophysiology, Vol. 18, No. 3, March 2007, U.S. Pat. No. 7,212,850 and Patent Appl. Pub No. US 2006/0084881 A1 of Korzinov et al.
Conventional systems also include wireless transmission of ECG data, as discussed in U.S. Pat. No. 5,522,396, a 12-lead Holter ECG system, as discussed in U.S. Pat. No. 6,690,967, and an event recorder system, as discussed in U.S. Pat. No. 5,876,351.
An AfibAlert device monitors for AF during a 45-second testing period. However, the AfibAlert device does not provide a continuous or real-time detection and monitoring of the heart, and therefore cannot alert if AF happens at any other time. In addition, the cost of the AfibAlert device is relatively high for wide acceptance by the general population. Furthermore, the 90-93% accuracy of the AfibAlert device is below the accuracy of the detection algorithm of the present invention.
A number of algorithms have been developed to detect AF. Such conventional algorithms can be categorized based on P-wave detection and an interbeat (RR) interval (RRI) variability (HRV). Since there is no uniform depolarization of the atria during AF, there is no discernible P-wave in the ECG. This fact has been utilized in detection of AF by trying to identify whether the P-wave is absent. However, in most cases the location of the P-wave fiducial point is very difficult to find. Moreover, the P-wave may be small enough to be corrupted by noise that is inherent in surface measurements. The methods in the second category do not require identification of the P-wave and are based on the variability of RRI series. However, few algorithms in this category show high predictive value for clinical application. A notable exception is discussed by Duverney et al. in High Accuracy of Automatic Detection of Atrial Fibrillation using Wavelet Transform of Heart Rate Intervals, Pacing Clin Electrophysiol 25: 457-462, 2002, and by Tateno et al. in Automatic Detection of Atrial Fibrillation using the Coefficient of Variation and Density Histograms of RR and delta RR Intervals, Medical & Biological Engineering & Computing 39: 664-671, 2001.
Duverney et al. use wavelet transform of an RRI time series where the sensitivity and specificity was 96.1% and 92.6% for AF beats, respectively, on a European database consisting of 15 subjects. Tateno et al. compare the density histogram of a test RRI (and ΔRRI) segment with previously compiled standard density histograms of RR (and ΔRR) segments during AF using the Kolmogorov-Smirnov test, to report a sensitivity of 94.4% and specificity of 97.2% for AF beats for the MIT BIH Atrial Fibrillation database. However, the accuracy of the Tateno et al. algorithm relies on the robustness of training data and that their results were based on a limited database. However, in most clinical applications, it may be difficult to obtain such large databases of training data.
In view of a general consideration of AF as being a random sequence of heart beat intervals with markedly increased beat-to-beat variability, the present invention combines four statistical techniques to exploit a Root Mean Square of Successive RR interval Differences to quantify variability (RMSSD), a Turning Points Ratio (TPR) to test for randomness of the time series, a Shannon Entropy (SE) to characterize its complexity and a autocorrelation (ACORR) index to characterize correlation between the first two RR intervals. In contrast to the Tateno-Glass method, the algorithm of the present invention does not require training data. See, Lu S, Chon K H, and Raeder E, Automatic Real Time Detection of Atrial Fibrillation, Heart Rhythm 4: S36 (2007).
The present invention provides a method and apparatus for utilizing an algorithm that accurately detects, in a real-time manner, the presence of AF utilizing piezoelectric or ECG signals. The present invention also provides a portable blood pressure cuff, for home monitoring.

SUMMARY OF THE INVENTION

The present invention provides a method for removal of ectopic beats, the method including obtaining consecutive patient heartbeats from an Atrial Fibrillation (AF) analysis and recognizing an ectopic beat by detecting a signature short-long sequence in an interbeat (RR) interval of the obtained heartbeats, with the signature short-long sequence including an ectopic coupling interval followed by a compensatory pause between RR intervals.
In an embodiment of the presenting invention, the ectopic beats and associated compensatory pause are excluded from the obtained consecutive patient heartbeats to create a clean time series. In another embodiment of the presenting invention, the compensatory pause is longer than the ectopic coupling interval.

BRIEF DESCRIPTION OF THE DRAWINGS

The above and other objects, features and advantages of certain exemplary embodiments of the present invention will be more apparent from the following detailed description taken in conjunction with the accompanying drawings, in which:

FIGS. 1( a)-(f) show threshold values for AF detection;

FIG. 2 shown shows results of a turning points analysis;

FIGS. 3( a)-(e) show an AF episode, including RMSSD, TPR, Shannon Entropy and ACORR;

FIG. 4 shows a piezoelectric sensor incorporated in a blood pressure cuff;

FIG. 5 provides a comparison of RR intervals obtained from a commercial ECG device and PPV values obtained utilizing the piezoelectric sensor of the present invention;

FIGS. 6( a)-(b) show an integrated wireless ECG device and wireless ECG collection of the present invention; and

FIG. 7 is a flowchart showing operation of a preferred embodiment of the present invention.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The following detailed description of preferred embodiments of the invention will be made in reference to the accompanying drawings. In describing the invention, explanation about related functions or constructions known in the art are omitted for the sake of clearness in understanding the concept of the invention, to avoid obscuring the invention with unnecessary detail.
A preferred embodiment of the present invention utilizes a Turning Points Ratio (TPR) to determine whether an RR interval sequence is random, for application of the TPR nonparametric statistical test comparing each point in the time series to neighboring points. Ectopic beats and associated compensatory pause are excluded from the obtained consecutive patient heartbeats to create a clean time series, i.e., devoid of premature beats, unperturbed by ectopic beats.
FIG. 1( a) shows an original heart beat interval time series from a section of file 5162 of a MIT BIH Atrial Fibrillation database. FIGS. 1( b)-(e) show calculation of the RMS SD, TPR, Shannon Entropy and ACORR, respectively, for the same segment. FIG. 1( f) shows final detection results based on whether the above statistics cross respective thresholds that are shown in dashed lines for FIGS. 1( b)-(c). In FIG. 1( a) a long-term recording is shown with an episode of AF embedded in normal sinus rhythm in which random behavior of AF is clearly observed. As shown in FIGS. 1( b) through (f), the combination of TPR, RMSSD, SE and ACORR greatly enhances the accuracy of AF detection.
In a computer generated random time series, the probability of an interval being surrounded by either two higher or two lower intervals (“Turning Point”) is equal to ⅔. Given three random numbers a₁,a₂,a₃where a₁>a₂>a₃, there are six combinations to generate a series. Among them, (a₁a₃a₂),(a₂a₃a₁),(a₂a₁a₃) and (a₃a₁a₂) include turning points while (a₁a₂a₃) and (a₃a₂a₁) do not. Given a random series of length n, the expected number of turning points is
$\frac{2 n - 4}{3},$
and the standard deviation is
$\sqrt{\frac{16 n - 29}{90}} .$
Hence, the expected Turning Points Ratio (TPR) of a random series is provided in Equation (1):
$\begin{matrix} TPR = \frac{2 n - 4}{3 n} \pm \sqrt{\frac{16 n - 29}{90}} & (1) \end{matrix}$
Confidence limits of this ratio are defined to estimate randomness boundaries in a time series. A series with ratios below the lower 95% confidence interval exhibits periodicity (e.g. sinus rhythm) whereas TPRs above the upper 95% confidence limit approaching 1.0 are evidence of alternans where ultimately every point is a turning point (“ABABAB” pattern).
FIG. 2 shows an analysis of one thousand (1000) random numbers subjected to turning points analysis. As expected, panel (a) shows the TPR of the random number sequence is ˜⅔. When increasing levels of alternans are imposed, as shown in panels (b) through (d), the TPR increases above the 95% confidence limit for randomness until approaching unity.
In the present invention, a Root Mean Square of Successive Differences is preferably performed as a second component of the algorithm. In the present invention, beat-to-beat variability is estimated by the root mean square of successive RR differences (RMSSD). Since AF exhibits higher variability between adjacent RR intervals than periodic rhythms such as sinus rhythm, the RMSSD is expected to be higher. For a given segment a(i) of RR intervals of some length 1, the RMSSD is given by Equation (2):
$\begin{matrix} RMSSD = \sqrt{\frac{1}{128}} \sum_{j}^{j + l = 1} {(a (j + 1) - a (j))}^{2} & (2) \end{matrix}$
A third component of the algorithm of the present invention is Shannon Entropy (SE), which provides quantitative information about the complexity of a signal. Complexity refers to the difficulty in describing or understanding a signal. For example, signals with discernible regular patterns are easier to describe than signals with a higher degree of irregularity. The SE quantifies how likely runs of patterns that exhibit regularity over a certain duration of data also exhibit similar regular patterns over the next incremental duration of data. For example, a random white noise signal is expected to have the highest SE value (1.0) whereas a simple sinusoidal signal will have a very low SE (˜0.2) value. Thus, the SE values of normal sinus rhythm and AF can be expected to differ significantly.
Calculation of SE of the RR interval time series is performed by first constructing a histogram of the segment considered. The eight maximum and eight minimum RR values in the segment are considered outliers and are removed from consideration. The remaining RR intervals are sorted into equally spaced bins whose limits are defined by the minimum and maximum RR interval after removing outliers. To obtain a reasonably accurate measure of the SE, at least 16 such bins are needed. Based on an ROC curve analysis, the segment length for AF detection was set at 128 beats.
An estimation of probability is performed as a next step in the calculation of SE, preferably by computing for each bin as the number of beats in that bin divided by the total number of beats in the segment (after removing outliers), for example see Equation (3):
$\begin{matrix} p (i) = \frac{No . ofbeatsinbin (i)}{Totalnumberofbeatsinthesegment} = \frac{No . ofbeatsinbin (i)}{128 - 16} = \frac{No . ofbeatsinbin (i)}{112} & (3) \end{matrix}$
The SE is then calculated utilizing Equation (4):
$\begin{matrix} SE = - \sum_{i = 1}^{16} p (i) \frac{\log (p (i))}{\log (\frac{1}{16})} & (4) \end{matrix}$
The autocorrelation function is also used to characterize correlation between among the current and past samples of RR intervals. A practical estimate is provided by Equation (5).
$\begin{matrix} {\hat{ϕ}}_{xx} (τ) = \frac{1}{R - τ} \int_{0}^{N} x (t) x (t - τ) \partial t & (5) \end{matrix}$
Thus, φ_xx(τ) is a measure of how correlated x(τ) is with its past value τ seconds earlier. For noisy or broadband data, the autocorrelation at all delays other than 0 will be close to 0. This fact is utilized for the detection of AF from its RR interval series by taking the difference between the autocorrelation at delay 0 and at delay 1 and comparing with some threshold. In addition, the autocorrelation at delay 0 is always normalized to 1 so as to enable comparison with a fixed and easy-to-compute threshold. A threshold of 0.02 was used for ACORR that is any value that is greater than 0.02 is considered as AF.
In the present invention, a filtering of ectopic beats is preferably also performed. Ectopic beats occurring during regular sinus rhythm are a potential cause of erroneous detection of AF since they confound all three components of the algorithm. Typically, a premature beat is characterized by the combination of a short coupling interval to the preceding normal RR interval, followed by a compensatory pause which is longer than both the ectopic coupling interval and the subsequent normal RR interval.
Thus, if the i-th RR interval is premature and the i-th+1 RR the compensatory pause, then RR[i−1]>RR[i]<RR[i+1] and RR[i]<RR[i+1]>RR[i+2], yielding at least two additional turning points and three if RR[i+1]>RR[i+2]<RR[i+3]. In order to recognize the characteristic short-long RR interval sequence of ectopic beats a ratio RR[i]/RR[i−1] is computed for each RR interval in the time series. For a regular sinus rhythm, this ratio is close to unity and fluctuations around it represent physiologic variability, referring to beat-to-beat RR interval adjustment caused by autonomic nervous control. In the case of ectopy, the sequence of ratios is RR[i]/RR[i−1]<0.8, RR[i+1]/RR[i]>1.3, and RR[i+2]/RR[i+1]<0.9. Preferably, rather than relying on an arbitrary fixed ratio, diverse ectopic beats with varying coupling intervals are captured by searching for RR sequences which satisfy the conditions RR[i]/RR[i−1]<Perc1 and RR[i+1]/RR[i]>Perc99 and RR[i+1]/RR[i+2]>Perc25 (where Perc1, Perc99, and Perc25 are the first, 99th, and 25th percentile of RR ratios, respectively). When an ectopic beat is encountered, it is excluded from further analysis along with its compensatory pause.
The present invention utilizes the following threshold definitions. Optimal cut-points for the algorithm of the present invention are identified by plotting the ROC for RMSSD, selecting a threshold that optimizes sensitivity so that a maximum number of possible AF beats can pass through to the next step. Such threshold definition minimizes the likelihood that true AF beats are filtered out in the first step of the analysis cascade.
In a preferred embodiment, a threshold of 9.8% of the mean RR interval of the 128-beat segment was used, based on inspection of the ROC, to yield a sensitivity and specificity of 99.1% and 79.33% for AF beats, respectively.
Next, keeping the RMSSD threshold fixed, a Turning Points analysis was added and a second ROC was constructed by varying only the confidence interval of the expected turning points ratio. As discussed above, the expected TPR of a random series is 0.666± confidence interval. The ROC is obtained by varying the confidence interval of the TPR and plotting the corresponding sensitivity against the specificity. Again, the TPR threshold is selected so as to maximize the sensitivity without compromising on the specificity (e.g. this resulted in the sensitivity and specificity of 97.06% and 86.47% for AF beats, respectively).
Based on this analysis, sensitivity and specificity for AF detection are optimal for a confidence interval of the TPR between 0.527 and 0.8. Using the same approach for SE reveals the optimal cut point to be 0.8. For the AFIB database (N=23 subjects), a threshold of 0.8 for the SE gave a sensitivity of 95.06% and specificity of 96.68% of all AF beats. Using the same criteria on the 200 series of the MIT BIH Arrhythmia database (N=25 subjects) gave a sensitivity of 88.13% and a specificity of 82.01% for AF beats. For the 100 series in the same database (N=23 subjects), the specificity was 98.38% for AF beats. Since there are no true AF beats in this series, the sensitivity cannot be quantified.
Testing was performed utilizing a 200 series of a MIT BIH Arrhythmia database (N=25 subjects), which is the most challenging database because it contains many artifacts, including Atrial Premature Beats (APB), Ventricular Premature Beats (VPB). Removal of VPB prior to data analysis was found to increase sensitivity and specificity on the 200 series of the MIT BIH Arrhythmia database to 88.24% and 88.01% for AF beats, respectively.
For clinical applications, a most relevant objective is detection of AF in a given recording, not necessarily every single AF beat. Using this criterion, a sensitivity of 100% was achieved for both the AF and arrhythmia databases. The results of use of the present invention are summarized in Table 1, which provides AF detection accuracy.

TABLE 1

		AF episodes
	AF beats (Sensitivity	(Sensitivity
Database	%/Specificity %)	%/Specificity %)

MIT-BIH AFIB (N = 23)	93.51/97.03	100/99.11
MIT-BIH Arrhythmia 100	NA/98.38 (note: no	NA
series (N = 23)	AF in this database)
MIT-BIH Arrhythmia 200	88.24/88.01	100/100
series (N = 25)
ScottCare Holter (N = 23)	Not available	100/96

Furthermore, automatic real time detection of AF in a clinical setting appears feasible with the combined use of TPR, RMSSD and SE, as the algorithm takes only 2.5 seconds to compute 24-hour Holter data which contains approximately 100,000 beats. The algorithm needs 1.5 to 2 minutes of RR interval data for an SE test of 128 beats, with computation time of a 128-beat data segment on the order of 1-2 milliseconds.
FIGS. 3( a)-(e) show an AF episode, including RMSSD, TPR, Shannon Entropy and ACORR, as an example calculation, with the final detection using the corresponding thresholds for a sample recording from the MIT BIH Atrial Fibrillation database. FIG. 3( a) shows an episode of AF embedded in Sinus Rhythm from the MIT-BIH Atrial Fibrillation database is shown, FIG. 3( b) shows an RMSSD, FIG. 3( c) shows a TPR, FIG. 3( d) shows SE, and FIG. 3( e) shows ACORR. Dotted lines in (b-e) represent threshold values as determined by the ROC. A final detection result as to whether an AF is detected is displayed in FIG. 1( f).
In another preferred embodiment of the present invention, a piezoelectric sensor is utilized to obtain RR intervals. This will facilitate a shift from current clinical practice of centralized AF detection (i.e. making the diagnosis at a doctor's office, clinic or hospital) to a distributed model relying on the patients themselves to obtain the data. The present invention “piggy-backs” on daily blood pressure checks made at home, in a pharmacy, or even in select stores. In the preferred embodiment, a signal is acquired through a blood pressure cuff adapted with an embedded piezoelectric sensor, to obviate the need for an electrocardiogram.
FIG. 4 shows a piezoelectric sensor incorporated into a blood pressure cuff for placement on a finger or on the brachial artery, and FIG. 5 provides a comparison of RR intervals obtained from a commercial ECG device and PPV obtained via a piezoelectric sensor.
A preferred embodiment of the present invention embeds a piezoelectric crystal in a blood pressure cuff, as shown in FIG. 4. A signal from the piezoelectric crystal is utilized to obtain statistical criteria to diagnosis/exclude AF. In the preferred embodiment, a peak systolic blood pressure is derived from successive heart beats. The preferred embodiment allows for remote patient monitoring in an essentially burden-free manner. The preferred embodiment allows diagnosis to be made of asymptomatic patients that is not addressed in conventional systems.
As shown in FIG. 5, a close correlation exists between ECG and piezoelectric sensor derived signals. The device of the present invention does not impose an additional burden on the patient, other than an additional three to five minute data collection period. Moreover, since recording of an electrocardiogram with its attendant cost is avoided, since the piezoelectric sensor is reusable and does not require separate energy source, the incremental cost is minuscule compared to the potential public health benefit.
FIG. 6( a) shows a prototype of a wireless two-channel ECG circuit and FIG. 6( b) shows wireless data collection of ECG developed in accordance with the present invention. FIG. 7 provides a flowchart summarizing data acquisition and the analysis algorithm.
While the invention has been shown and described with reference to certain exemplary embodiments of the present invention thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the present invention as defined by the appended claims and equivalents thereof.

Claims

What is claimed is:

1. A method for removal of ectopic beats, the method comprising:

obtaining consecutive patient heartbeats; and

recognizing an ectopic beat by detecting a signature short-long sequence in an interbeat interval of the obtained heartbeats,

wherein the signature short-long sequence comprises an ectopic coupling interval followed by a compensatory pause between RR intervals.

2. The method of claim 1, wherein ectopic beats and an associated compensatory pause are excluded from the obtained consecutive patient heartbeats to create a clean time series.

3. The method of claim 2, wherein the compensatory pause is longer than the ectopic coupling interval.

4. The method of claim 1, further comprising computing a ratio of RR[i]/RR[i−1] for each interbeat interval, wherein RR[i] is an ectopic beat interval.

5. The method of claim 4, wherein a sinus rhythm is identified when the computed ratio is near unity.

6. The method of claim 1, wherein a compensatory pause (RR[i+1]) following a premature interbeat interval (RR[i]) is detected by:

RR[i−1]>RR[i]<RR[i+1], and

RR[i]<RR[i+1]>RR[i+2],

wherein RR[i] is an ectopic beat interval.

7. The method of claim 1, wherein the consecutive patient heartbeats are obtained from an Atrial fibrillation analysis.